Lanzamiento Enero 2027

Ensayo controlado aleatorizado2007Financiación no declaradaSolo mecanismos

Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas

Courtney ED, Matthews S, Finlayson C, Di Pierro D, Belluzzi A, Roda E, Kang JY, Leicester RJ

International journal of colorectal disease · 80 citas

Etiquetas de revisión

Financiación no declaradaSolo mecanismos

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Solo mecanismos

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2007-01-09 · Int J Colorectal Dis · vol. 22 · número 7 · págs. 765–776
Editorial
Springer Science+Business Media
Citado
125 citas · más que el 99% de estudios similares · 12.4× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
47 trabajos
Acceso
De pago
Áreas de investigación
Fatty Acid Research and Health · Inflammatory mediators and NSAID effects · Colorectal Cancer Screening and Detection
Palabras clave
eicosapentaenoic acid, omega-3 fatty acids, fish oil supplementation, colorectal adenoma, crypt cell proliferation, apoptosis, colonic mucosa, colorectal cancer chemoprevention, dietary supplementation
MeSH
intestinal mucosa, colon, humans, adenoma, colorectal neoplasms, eicosapentaenoic acid, fatty acids, colonoscopy, biopsy, treatment outcome, immunohistochemistry, administration, oral, retrospective studies, follow-up studies, apoptosis, cell proliferation, middle aged, female, male

8 autores

  • E. D. Courtney🇬🇧 · autor de correspondenciaSt George's Hospital; Luton and Dunstable Hospital; St George's Hospital
  • S. Matthews🇬🇧St George's Hospital; St George's Hospital
  • Caroline J. Finlayson🇬🇧St George's Hospital; St George's Hospital
  • Donato Di Pierro🇮🇹University of Bologna
  • Andrea Belluzzi🇮🇹University of Bologna
  • E. Roda🇮🇹University of Bologna
  • Jin-Yong Kang🇬🇧St George's Hospital; St George's Hospital
  • Roger J. Leicester🇬🇧St George's Hospital; St George's Hospital

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background and aims

Omega-3 fatty acids in fish oil exert a protective effect on the development of colorectal cancer in animal models. Patients with colorectal adenomas have been shown to have increased crypt cell proliferation and decreased apoptosis in macroscopically normal appearing colonic mucosa. We investigated whether dietary supplementation with eicosapentaenoic acid (EPA) could alter crypt cell proliferation and apoptosis in such patients.

Patients/methods

Thirty subjects were randomised to either 3 months of highly purified EPA in free fatty acid form (2 g/day) or to no treatment. Colonic biopsies were taken at the initial colonoscopy and repeated 3 months later, and analysed for cell proliferation and apoptosis (immunohistochemistry) and mucosal fatty acid content.

Results/findings

Crypt cell proliferation was significantly reduced whilst apoptosis was significantly increased after EPA supplementation. Neither crypt cell proliferation nor apoptosis were altered in the control group. EPA in the mucosa increased significantly after EPA supplementation, whereas there was no significant change in controls.

Conclusions

Dietary supplementation with EPA significantly increases levels of this fatty acid in colonic mucosa, associated with significantly reduced proliferation and increased mucosal apoptosis. Further studies are needed to assess the potential efficacy of EPA supplementation in preventing polyps in the chemoprevention of colorectal cancer.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.